Bank of New York Mellon Corp Sells 20,316 Shares of American Vanguard Co. (NYSE:AVD)

Bank of New York Mellon Corp reduced its stake in American Vanguard Co. (NYSE:AVD) by 16.8% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 100,937 shares of the basic materials company’s stock after selling 20,316 shares during the period. Bank of New York Mellon Corp owned about 0.36% of American Vanguard worth $868,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in AVD. Gladius Capital Management LP bought a new stake in shares of American Vanguard during the second quarter worth $32,000. Nisa Investment Advisors LLC grew its position in American Vanguard by 7,554.5% during the 2nd quarter. Nisa Investment Advisors LLC now owns 4,210 shares of the basic materials company’s stock worth $36,000 after acquiring an additional 4,155 shares during the last quarter. EntryPoint Capital LLC increased its holdings in American Vanguard by 363.9% in the 1st quarter. EntryPoint Capital LLC now owns 10,118 shares of the basic materials company’s stock worth $131,000 after purchasing an additional 7,937 shares in the last quarter. Aristides Capital LLC bought a new position in American Vanguard in the fourth quarter valued at about $132,000. Finally, Humankind Investments LLC acquired a new stake in shares of American Vanguard during the fourth quarter valued at about $159,000. 79.04% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several research analysts have recently issued reports on the company. StockNews.com downgraded American Vanguard from a “hold” rating to a “sell” rating in a research note on Tuesday, August 13th. Lake Street Capital assumed coverage on shares of American Vanguard in a research report on Monday, July 22nd. They issued a “buy” rating and a $14.00 price target for the company. One research analyst has rated the stock with a sell rating and four have issued a buy rating to the company. According to MarketBeat, American Vanguard currently has a consensus rating of “Moderate Buy” and a consensus target price of $16.67.

Insider Activity

In other news, Director Keith M. Rosenbloom bought 104,492 shares of the stock in a transaction that occurred on Friday, August 30th. The stock was acquired at an average price of $5.74 per share, with a total value of $599,784.08. Following the completion of the purchase, the director now directly owns 1,168,682 shares of the company’s stock, valued at $6,708,234.68. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other American Vanguard news, Director Keith M. Rosenbloom bought 104,492 shares of the business’s stock in a transaction that occurred on Friday, August 30th. The shares were bought at an average price of $5.74 per share, for a total transaction of $599,784.08. Following the transaction, the director now directly owns 1,168,682 shares in the company, valued at $6,708,234.68. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Keith M. Rosenbloom bought 25,000 shares of the stock in a transaction on Tuesday, September 3rd. The stock was acquired at an average price of $5.94 per share, with a total value of $148,500.00. Following the completion of the acquisition, the director now owns 1,193,682 shares of the company’s stock, valued at approximately $7,090,471.08. The disclosure for this purchase can be found here. In the last three months, insiders have bought 163,047 shares of company stock valued at $938,205. 10.10% of the stock is currently owned by insiders.

American Vanguard Trading Down 5.4 %

NYSE AVD opened at $5.56 on Friday. American Vanguard Co. has a 12 month low of $4.95 and a 12 month high of $14.28. The company has a current ratio of 2.22, a quick ratio of 1.08 and a debt-to-equity ratio of 0.60. The firm has a market capitalization of $155.60 million, a PE ratio of 21.38 and a beta of 0.88. The business’s 50-day moving average price is $7.04 and its two-hundred day moving average price is $9.18.

American Vanguard (NYSE:AVD) last announced its earnings results on Thursday, August 8th. The basic materials company reported ($0.09) EPS for the quarter, missing the consensus estimate of ($0.01) by ($0.08). American Vanguard had a negative net margin of 0.60% and a positive return on equity of 1.85%. The company had revenue of $128.21 million during the quarter, compared to the consensus estimate of $134.20 million. On average, analysts expect that American Vanguard Co. will post 0.02 EPS for the current year.

American Vanguard Profile

American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. It manufactures and formulates chemicals, including insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection.